Ayala Pharmaceuticals EV/Sales
Cos'è EV/Sales di Ayala Pharmaceuticals?
EV/Sales di Ayala Pharmaceuticals Inc. è N/A
Qual è la definizione di EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales di aziende nel Health Care settore su NASDAQ rispetto a Ayala Pharmaceuticals
Cosa fa Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Aziende con ev/sales simili a Ayala Pharmaceuticals
- Tissue Repair Ltd ha EV/Sales di N/A
- Catheter Precision ha EV/Sales di N/A
- Mirasol Resources ha EV/Sales di N/A
- Acasti Pharma Inc ha EV/Sales di N/A
- Pembroke Venture Capital Trust ha EV/Sales di N/A
- Maven Income & Growth VCT ha EV/Sales di N/A
- Ayala Pharmaceuticals ha EV/Sales di N/A
- Yatra Capital ha EV/Sales di N/A
- SREI Infrastructure Finance ha EV/Sales di N/A
- Aquarius AI ha EV/Sales di N/A
- Mobeus Income & Growth 4 VCT plc ha EV/Sales di N/A
- FAR ha EV/Sales di N/A
- Clean Power Capital ha EV/Sales di N/A